Thursday, July 9, 2026

pharma · Familial adenomatous polyposis (FAP) · Familial Adenomatous Polyposis · BDRX

Biodexa Pharmaceuticals

Biodexa Pharmaceuticals trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

cardiff, GB HQ
2000 Founded
25 Employees
Public company Type
BDRX · NYSE Ticker
Company details
Status
Public
HQ
cardiff, GB
Founded
2000
Employees
25
Programs
4
Drugs
5
Patents
2
Intelligence · Clinical Trials

Biodexa Pharmaceuticals clinical trials

Registry index of 4 ClinicalTrials.gov studies linked to Biodexa Pharmaceuticals programs — each row shows trial ID, program name, phase, status, and indication.

Biodexa Pharmaceuticals trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

4 updates

Latest clinical program signals indexed for Biodexa Pharmaceuticals.

  1. MTX230-301 — Phase 3

    Clinical update
  2. eRapa (encapsulated rapamycin) — Phase 3

    Clinical update
  3. Encapsulated Rapamycin (eRapa) — Phase 2

    Clinical update
  4. MTX110 — Phase 1

    Clinical update

Trial registry

4 studies